Harvey Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-17,400
Closed -$730K 66
2013
Q2
$730K Buy
+17,400
New +$730K 0.45% 41